$INO Recent Headlines Monday's biggest gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Jan 9, 2014 at 10:55 PM

$INO Recent Headlines

Monday's biggest gaining and declining stocks 4:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 11:31 a.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 9:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 10:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 5:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 5:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 4:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 5:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 5:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 9:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 6:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 6:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 9:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 5:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 5:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 5:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 5:05 a.m. May 12, 2005 - Steve Goldstein

Mid-Afternoon Market Update: Markets Mixed as Airlines Show a Boost in Traffic 2:31 p.m. Jan. 3, 2014 - benzinga.com
Inovio, Chelsea struggle after Feuerstein mention 11:58 a.m. Jan. 3, 2014 - Seeking Alpha
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Today's Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 9:48 a.m. Dec. 27, 2013 - TheStreet.com
Inovio Pharmaceuticals (INO) Soars: Stock Zooms 20.2% - Tale of the Tape 8:51 a.m. Dec. 27, 2013 - Zacks.com
Arena, Inovio rally after positive mention 10:57 a.m. Dec. 26, 2013 - Seeking Alpha
3 Biotechs That Could Double In 2014 8:48 a.m. Dec. 26, 2013 - Seeking Alpha
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014 11:30 a.m. Dec. 20, 2013 - Seeking Alpha
Buy Inovio Due To Insider Interest And Upcoming Trial Results 8:21 a.m. Dec. 19, 2013 - Seeking Alpha
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting 1:46 p.m. Dec. 17, 2013 - Seeking Alpha
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem 9:14 a.m. Dec. 4, 2013 - Seeking Alpha
2 Small Speculative Biotech Plays Moving On News 9:55 a.m. Nov. 21, 2013 - Seeking Alpha
Insider Interest, Positive Trial Data And Upcoming Catalysts, Everything Is Going For In 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
UNIS Stock Explodes By Nearly 50%, Slowing Its Race to the Bottom 8:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Inovio Pharma jumps on MERS vaccine news 8:22 a.m. Nov. 20, 2013 - Seeking Alpha
Inovio Pharmaceutical's DNA Vaccine for MERS Virus Shows Promising Results in Preclinical Trial 4:44 a.m. Nov. 20, 2013 - benzinga.com
Insider Trading Alert - INO, PSMT, CBI, BRS And EHTH Traded By Insiders 12:02 p.m. Nov. 15, 2013 - TheStreet.com
Treating Melanoma: Only The Best Shall Survive 3:31 p.m. Nov. 13, 2013 - Seeking Alpha

Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference 4:00 a.m. Jan. 6, 2014 - PR Newswire
AAAResearchReports.com Pre-Market Technical Analysis: Inovio Pharma, Sequenom, Nektar Therapeutics, and Discovery Laboratories 8:23 a.m. Dec. 17, 2013 - PR Newswire
CEO Dr. Joseph Kim to Discuss Inovio's Innovative Approach to Treating Cervical Cancer in an Expert Panel 8:05 a.m. Dec. 11, 2013 - PR Newswire
Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial 3:05 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Appointed to International Vaccine Institute Board of Trustees 4:00 a.m. Nov. 19, 2013 - PR Newswire
International Vaccine Institute Announces Appointments of New Members to its Board of Trustees 8:00 p.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Upcoming Investor Conferences 4:00 a.m. Nov. 18, 2013 - PR Newswire
Inovio Pharmaceuticals CEO Receives 2013 Drug Discovery & Achievement Award 12:00 a.m. Nov. 14, 2013 - PR Newswire
Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:33 a.m. Nov. 12, 2013 - PR Newswire
Inovio Pharmaceuticals to Host Third Quarter 2013 Earnings Webcast Live on Tuesday, November 12, 2013 9:32 a.m. Nov. 11, 2013 - ACCESSWIRE
Inovio Pharmaceuticals to Report Third Quarter 2013 Financial Results on November 12, 2013 4:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 8:00 a.m. Oct. 28, 2013 - PR Newswire
Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial 3:00 a.m. Oct. 21, 2013 - PR Newswire
Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc. 8:27 a.m. Oct. 4, 2013 - PR Newswire
Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum 3:00 a.m. Oct. 1, 2013 - PR Newswire
Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies 4:12 a.m. Sept. 24, 2013 - PR Newswire
Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles 3:00 a.m. Sept. 18, 2013 - PR Newswire
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership with Roche 3:10 a.m. Sept. 10, 2013 - PR Newswire
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products 3:00 a.m. Sept. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

High Stakes at Bragg Companies' Crane Auction

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Kastle Partners with Bilt: Enhancing Workplace Rewards

Turning the Office into a Rewarding Experience It’s no secret the traditional office work setup is constantly evolving, often giving the workplace a brand-new set of challenges—and opportunities. Who would have thought that a partnership between Kastle and Bilt would set gears turning? The dynamic duo is about to redefine how people see going to the office. Kastle, a...

Bluerock's Split: What November's Trading Change Means

Bluerock's Strategic Move: Untying the Bundle Ah, Bluerock Acquisition Corp. II has thrown a new bone to the market. Starting November 16, 2026, the firm ain't keeping their Class A ordinary shares and warrants locked in a bundle anymore. This shift comes after they sold 17,250,000 units in their IPO back in September, which also saw underwriters fully clinking their...

Envista's $430M Senior Notes: A Market Move Decoded

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Fake Profiles Dominate Daters' Trust Issues Today

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

Plaza Tire Opens New Location on Route 66 Corridor

Expanding Horizons in the Midwest Another chapter in Plaza Tire Service's long history, folks, as it plants its flag deeper in Missouri with a new store right on the iconic Route 66. Yep, that means more options for drivers in central Missouri who've had enough of searching high and low for a reliable tire and auto service. What's New in St. Robert This latest joint isn't...

Li-Fire Tackles E-Bike Battery Fires Head-On

By Owen Jenkins Updated Nov 10, 2026 Category News Views 121

E-Bike Enthusiasm Meets Dangerous Fire Risks Imagine this: your sleek new e-bike, your pride and joy, becomes a ticking time bomb. That's the reality facing more folks than we'd like these days, as e-bike battery fires surge across the globe. Amidst the holiday hustle, Li-Fire hits the scene with a lifeline—a free replacement program for their E-bike Lithium Fire Cover....

Kia's Landmark Triple Win at 2026 Car Awards

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

TIER IV and TUM Propel Driverless Buses in Munich

Revolutionizing Munich's Public Transit Let's dive headlong into one of the most ambitious autonomous driving projects that's underway in Europe's tech heart—Munich. Pioneering organizations, TIER IV and the Technical University of Munich (TUM), are combining forces to bring autonomous city buses to the bustling streets of Munich, powered by Autoware, the leading...

Yeastar 2026 Summit: AI, Growth, and Global Vision

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...